Research


Use of Bayesian Decision Analysis to Minimize Harm in Patient-Centered Randomized Clinical Trials in Oncology

with Vahid Montazerhodjat; Shomesh E. Chaudhuri; Daniel J. Sargent, JAMA Oncology (2017)

View abstract

Business Models to Cure Rare Disease: A Case Study of Solid Biosciences

with Esther S. Kim, Forthcoming Journal of Investment Mangement

View abstract

Health, Wealth, and the 21st Century Cures Act

with Tomas Philipson and Andrew von Eschenbach, JAMA Oncology 2(2016), 17–18.

View abstract

Price, Value, and the Cost of Cancer Drugs

with Tito Fojo  , Lancet Oncology 17(2016), 3–5.

View abstract

Business Models to Cure Rare Disease: A Case Study of Solid Biosciences

with Esther Kim, Journal of Investment Management 14(2016), 87–101.

View abstract

‘Health care loans’ for Hep C cure

with David Weinstock, The Boston Globe

View abstract

Buying Cures Versus Renting Health: Financing Health Care with Consumer Loans

with Vahid Montazerhodjat and David M. Weinstock, Science Translational Medicine 8(2016), 327ps6.

View abstract

Is the FDA Too Conservative or Too Aggressive?: A Bayesian Decision Analysis of Clinical Trial Design

with Leah Isakov and Vahid Montazerhodjat

View abstract

Lessons From Hollywood: A New Approach To Funding R&D

with Gary P. Pisano, Sloan Management Review 57(2015), 47–57.

View abstract

Megafunding Drug Research

with Edward Jung, Project Syndicate

View abstract

Follow me on © 2017 Andrew W. Lo, MIT Sloan School of Management. All rights reserved.
Design by: Opus Design